Specifically for these pro-AMPs, inhaled delivery allows direct access to the high levels of the activating enzyme NE on the respiratory surface, the concentrations of which can approach over 100 μM in vivo in CF [9], although varying greatly from patient to patient [10]. The gene discussed is ADSL; the disease is cystic fibrosis.